Peritoneal surface malignancies are cancers that grow or spread along the peritoneal surfaces, the tissues inside the abdomen. In the past, someone diagnosed with these challenging cancers had a very poor prognosis, but many of our patients now live full, active lives after treatment. Often, the disease is even curable.

Such advances are due in large part to our program leader, Dr. Paul Sugarbaker, a surgical oncologist who is considered one of the world’s leading experts in treating peritoneal surface malignancies. He has spent more than 30 years researching and developing the best approaches.

We welcome the chance to help you with an initial diagnosis or offer a second opinion.

Peritoneal Surface Malignancy Care 

Our program features:

  • Unmatched Expertise: Dr. Sugarbaker was part of the National Institutes of Health team in the 1980s that developed the idea of combining (cytoreductive) surgery with immediate chemotherapy — hyperthermic intraperitoneal chemotherapy, or HIPEC. He has since performed the combined procedure more than 1,700 times—running clinical trials, teaching other doctors the best approach, and helping make it the standard of care.
  • Team Approach: In addition to Dr. Sugarbaker, our team includes experienced surgical oncologists, medical oncologists, and support staff, all ready to deliver excellent, advanced care.
  • Careful and Comprehensive Evaluation: Before recommending a treatment, our team completes a thorough evaluation to ensure an accurate diagnosis and identification of the best approach. We spend time with you and your family to explain the findings and the options, making sure all your questions are answered and concerns addressed.